Cargando…

Comparative efficacy and safety of lipid-lowering agents in patients with hypercholesterolemia: A frequentist network meta-analysis

BACKGROUND: The comparative efficacy and safety of PCSK9 inhibitors, statins, and ezetimibe to lower lipid levels in patients with hypercholesterolemia remain unknown. We aimed to investigate the benefits and harms of the lipid-lowering agents in these patients. METHODS: PubMed, Embase, and the Coch...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhao, Zonglei, Du, Song, Shen, Shuxin, Luo, Ping, Ding, Shoukun, Wang, Guanggong, Wang, Lixia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer Health 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6380691/ https://www.ncbi.nlm.nih.gov/pubmed/30732185 http://dx.doi.org/10.1097/MD.0000000000014400

Ejemplares similares

Toll-like receptor 2 downregulates the cholesterol efflux by activating the nuclear factor-κB pathway in macrophages and may be a potential therapeutic target for the prevention of atherosclerosis
por: Li, Yongqiang, et al.
Publicado: (2018)

Acupuncture and Moxibustion for Peripheral Neuropathic Pain: A Frequentist Network Meta-Analysis and Cost-Effectiveness Evaluation
por: Zhao, Weixuan, et al.
Publicado: (2022)

Effectiveness and Safety of Lipid-Lowering Drug Treatments in Japanese Patients with Familial Hypercholesterolemia: Familial Hypercholesterolemia Expert Forum (FAME) Study
por: Yamashita, Shizuya, et al.
Publicado: (2022)

Pharmacogenomics Variability of Lipid-Lowering Therapies in Familial Hypercholesterolemia
por: Hindi, Nagham N., et al.
Publicado: (2021)

Introduction to Frequentist and Bayesian Fitting
por: James, F
Publicado: (2007)

Bayesian and frequentist regression methods
por: Wakefield, Jon
Publicado: (2013)

Frequentist Hypothesis Testing with Background Uncertainty
por: Cranmer, K
Publicado: (2003)

Bayesian versus frequentist upper limits
por: Rover, Christian, et al.
Publicado: (2011)

Frequentist analyses of solar neutrino data
por: Creminelli, Paolo, et al.
Publicado: (2001)

Properties of frequentist confidence levels derivatives
por: Martínez, Miriam Lucio, et al.
Publicado: (2016)

Frequentist and Bayesian Quantum Phase Estimation
por: Li, Yan, et al.
Publicado: (2018)

Efficacy and Safety of Alirocumab in Patients with Heterozygous Familial Hypercholesterolemia not Adequately Controlled with Current Lipid-Lowering Therapy: Design and Rationale of the ODYSSEY FH Studies
por: Kastelein, John J. P., et al.
Publicado: (2014)

Use of Statins as Lipid Lowering Agent in Hypercholesterolemia in a Tertiary Care Hospital: A Descriptive Cross-sectional Study
por: Bhattarai, Ashish Kumar, et al.
Publicado: (2020)

A comparison of the Bayesian and frequentist approaches to estimation
por: Samaniego, Francisco J
Publicado: (2010)

Frequentist Analysis of the Parameter Space of Minimal Supergravity
por: Buchmueller, O., et al.
Publicado: (2010)

Enhancing the physical significance of Frequentist confidence intervals
por: Giunti, C
Publicado: (2000)

Frequentist versus Bayesian approaches to multiple testing
por: Sjölander, Arvid, et al.
Publicado: (2019)

A Frequentist Opting for the Road Less Traveled
por: Alasnag, Mirvat, et al.
Publicado: (2022)

Frequentist against Bayesian statistics: tug of war!
por: Nair, Abhijit
Publicado: (2022)

Efficacy and safety of alirocumab in patients with hypercholesterolemia not adequately controlled with non-statin lipid-lowering therapy or the lowest strength of statin: ODYSSEY NIPPON study design and rationale
por: Teramoto, Tamio, et al.
Publicado: (2017)

Modified frequentist analysis of search results (the $CL_{s}$ method)
por: Read, A L
Publicado: (2000)

Case Report: Cardiac Surgery and Combined Lipid-Lowering Drug Therapy for Homozygous Familial Hypercholesterolemia
por: Gao, Mingxin, et al.
Publicado: (2020)

Familial Hypercholesterolemia: The Lipids or the Genes?
por: Fahed, Akl C, et al.
Publicado: (2011)

GENetic characteristics and REsponse to lipid-lowering therapy in familial hypercholesterolemia: GENRE-FH study
por: Kim, Hyoeun, et al.
Publicado: (2020)

Efficacy and Safety of Bempedoic Acid in Patients With Hypercholesterolemia and Statin Intolerance
por: Laufs, Ulrich, et al.
Publicado: (2019)

Efficacy and Safety of Lomitapide in Japanese Patients with Homozygous Familial Hypercholesterolemia
por: Harada-Shiba, Mariko, et al.
Publicado: (2017)

Longer-Term Efficacy and Safety of Evinacumab in Patients With Refractory Hypercholesterolemia
por: Rosenson, Robert S., et al.
Publicado: (2023)

Generalized Jeffrey conditionalization: a frequentist semantics of partial conditionalization
por: Draheim, Dirk
Publicado: (2017)

A Frequentist analysis of three right-handed neutrinos with GAMBIT
por: Chrzaszcz, Marcin, et al.
Publicado: (2019)

Practical Statistics for LHC Physicists: Frequentist Inference (2/3)
por: Prosper, Harrison
Publicado: (2015)

Bayesians versus frequentists: a philosophical debate on statistical reasoning
por: Vallverdú, Jordi
Publicado: (2016)

Generalized Empirical Bayes Modeling via Frequentist Goodness of Fit
por: Mukhopadhyay, Subhadeep, et al.
Publicado: (2018)

Comparison of Bayesian and frequentist methods for prevalence estimation under misclassification
por: Flor, Matthias, et al.
Publicado: (2020)

Comparison of Bayesian and frequentist group-sequential clinical trial designs
por: Stallard, Nigel, et al.
Publicado: (2020)

Empirical Frequentist Coverage of Deep Learning Uncertainty Quantification Procedures
por: Kompa, Benjamin, et al.
Publicado: (2021)

Frequentist Model Averaging in Structure Equation Model With Ordinal Data
por: Jin, Shaobo
Publicado: (2022)

Interpreting frequentist hypothesis tests: insights from Bayesian inference
por: Sidebotham, David, et al.
Publicado: (2023)

Novel Experimental Agents for the Treatment of Hypercholesterolemia
por: Pećin, Ivan, et al.
Publicado: (2021)

Aortic Valvular Disease in Elderly Subjects with Heterozygous Familial Hypercholesterolemia: Impact of Lipid-Lowering Therapy
por: Marco-Benedí, Victoria, et al.
Publicado: (2019)

An update on lipid apheresis for familial hypercholesterolemia
por: Taylan, Christina, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_6bnoupp0bkvr6krpt9oe09p5vq